Stallergenes

Stallergenes

Stallergenes is focused on the development, manufacture, and distribution of immunotherapeutic treatments for food-related and environmental allergies. The company has brought together experts from the fields of biology, botany, and the health community to collaborate on finding ways to deliver relief to people who suffer with problems ranging from asthma to seasonal allergies. These immunotherapy treatments involve conditioning the patient with drugs that introduce pure extracts of the allergen to initiate the body's own natural defenses against it. Wendel Investissement owns about 49% of the company. Stallergenes has research laboratories in Africa, the Americas, Asia, Australia, Europe, and the Middle East.

Contact Details

Office Address

Stallergenes
6 rue Alexis de Tocqueville
Antony Cedex, FRANCE 92183
Phone: +33-1-55-59-20-00
Fax: +33-1-55-59-20-02

Executives

Chairman and CEO

Albert Saporta

Managing Director

Louis Champion

Business Reviews for Stallergenes

Related Companies